DARIE GILLIAM: Open Payments
NPI 1174526883 · CLINTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$293 in 15 payments from 9 companies in 2025. Trend: 2023 $146 · 2024 $276 · 2025 $293
Food & beverage: $293
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $76 |
| Novo Nordisk Inc | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Exact Sciences Corporation | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Indivior Inc. | 1 | $22 |
| PFIZER INC. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: VRAYLAR, REXULTI, Cologuard Collection Kit, CAPLYTA, SUBLOCADE, Ozempic, TRUMENBA, Auvelity.
Industry payments across LA — which companies pay providers there.
